相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth
Michael Dewaele et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma
Joonil Jung et al.
NATURE COMMUNICATIONS (2016)
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond
Jean-Christophe Marine et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells
Z. Matijasevic et al.
ONCOGENESIS (2016)
Detained introns are a novel, widespread class of post-transcriptionally spliced introns
Paul L. Boutz et al.
GENES & DEVELOPMENT (2015)
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y. -T. Hsu et al.
NATURE (2015)
MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
Cheryl M. Koh et al.
NATURE (2015)
MDMX exerts its oncogenic activity via suppression of retinoblastoma protein
H. Zhang et al.
ONCOGENE (2015)
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing
Maayan Salton et al.
NATURE COMMUNICATIONS (2015)
Semi-supervised Learning Predicts Approximately One Third of the Alternative Splicing Isoforms as Functional Proteins
Yanqi Hao et al.
CELL REPORTS (2015)
Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity
B. Bardot et al.
ONCOGENE (2015)
Mdmx promotes genomic instability independent of p53 and Mdm2
A. M. Carrillo et al.
ONCOGENE (2015)
The functional consequences of intron retention: Alternative splicing coupled to NMD as a regulator of gene expression
Ying Ge et al.
BIOESSAYS (2014)
Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival
M. Fang et al.
ONCOGENE (2014)
SRp20: An overview of its role in human diseases
Claudia Corbo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery
Marco Bezzi et al.
GENES & DEVELOPMENT (2013)
MDMX contains an autoinhibitory sequence element
Michal Bista et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mutant Mice Lacking the p53 C-Terminal Domain Model Telomere Syndromes
Iva Simeonova et al.
CELL REPORTS (2013)
Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
Kristiaan Lenos et al.
CANCER RESEARCH (2012)
MDM4 is a key therapeutic target in cutaneous melanoma
Agnieszka Gembarska et al.
NATURE MEDICINE (2012)
Validation of MdmX as a therapeutic target for reactivating p53 in tumors
Daniel Garcia et al.
GENES & DEVELOPMENT (2011)
Functions of MDMX in the Modulation of the p53-Response
Kristiaan Lenos et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
Identification of Evolutionarily Conserved Exons as Regulated Targets for the Splicing Activator Tra2β in Development
Sushma Grellscheid et al.
PLOS GENETICS (2011)
A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
Federico Bernal et al.
CANCER CELL (2010)
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Charles J. David et al.
GENES & DEVELOPMENT (2010)
HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis
Mei Liang et al.
MODERN PATHOLOGY (2010)
Widespread Overexpression of Epitope-Tagged Mdm4 Does Not Accelerate Tumor Formation In Vivo
Sarah De Clercq et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
The Spliceosome: Design Principles of a Dynamic RNP Machine
Markus C. Wahl et al.
CELL (2009)
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties
Andrea Prodosmo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
MdmX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice
Zdenka Matijasevic et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Alternative splicing: an emerging topic in molecular and clinical oncology
Maria J. Pajares et al.
LANCET ONCOLOGY (2007)
Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death
L. S. M. Boesten et al.
CELL DEATH AND DIFFERENTIATION (2006)
Regulating the p53 pathway:: in vitro hypotheses, in vivo veritas
Franck Toledo et al.
NATURE REVIEWS CANCER (2006)
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo
Ingo Ringshausen et al.
CANCER CELL (2006)
Inactivation of the p53 pathway in retinoblastoma
Nikia A. Laurie et al.
NATURE (2006)
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network
F Toledo et al.
CANCER CELL (2006)
Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development
SB Xiong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo
S Francoz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4
JD Grier et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development
HA Steinman et al.
ONCOGENE (2005)
Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis
F Bartel et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth
HA Steinman et al.
ONCOGENE (2004)
Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells
R Rallapalli et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target
MJ Riemenschneider et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Expression and role of Bcl-xL in human hepatocellular carcinomas
T Takehara et al.
HEPATOLOGY (2001)
Alternative splicing: increasing diversity in the proteomic world
BR Graveley
TRENDS IN GENETICS (2001)
分享论文
